Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
The Korean Journal of Parasitology. 2021;59(3):189-225 
Treatment of Breast and Colon Cancer Cell Lines with Anti-Helmintic Benzimidazoles Mebendazole or Albendazole Results in Selective Apoptotic Cell Death
. 2021;
Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death
Journal of Cancer Research and Clinical Oncology. 2021;147(10):2945-2953
Antibodies and antibody-fusion proteins as anti-angiogenic, anti-tumor agents
Update on Cancer Therapeutics. 2006;1(2):159-173
Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer
Life Sciences. 2022;299:120536
Diabetic retinal disease: an update on the use of anti-VEGF agents
Practical Diabetes. 2013;30(2):50-51a
CORRIGENDUM A Promising Anti-Cancer and Anti-Oxidant Agents Based on the Pyrrole and Fused Pyrrole: Synthesis, Docking Studies and Biological Evaluation
Anti-Cancer Agents in Medicinal Chemistry. 2019;18(10):1505-1505
Therapy of human hydatid disease with mebendazole and albendazole
Antimicrobial Agents and Chemotherapy. 1993;37(8):1679-1684
Discovery and Development of Anti-Breast Cancer Agents From Natural Products: An Overview
Discovery and Development of Anti-Breast Cancer Agents from Natural Products. 2021;1-6
Venoms as Sources of Novel Anti-parasitic Agents
Toxins and Drug Discovery. 2015;1-31